Comparison of four different peptides to enhance accumulation of liposomes into the brain

References

• Aparna Nori, Keith D. Jensen, Monica Tijerina, Pavla Kopecˇkovaá, Jindˇrich Kopecˇek. (2003). Subcellular trafficking of HPMA copolymer–Tat conjugates in human ovarian carcinoma cells. Journal of Controlled Release, 91, 53–59.
   PubMed Web of Science ®Google Scholar
• Azadeh Kheirolomoom, Katherine W, Ferrara. (2007). Cholesterol transport from liposomal delivery vehicles. Biomaterials, 28, 4311–4320.
   PubMed Web of Science ®Google Scholar
• de Boer AG, Gaillard PJ. (2007). Drug targeting to the brain. Annu Rev Pharmacol Toxicol, 47, 323–355.
   PubMed Web of Science ®Google Scholar
• Janssen AP, Schiffelers RM, ten Hagen TL, Koning GA, Schraa AJ, Kok RJ, Storm G, Molema G. (2003). Peptide-targeted PEG-liposomes in anti-angiogenic therapy. Int J Pharm, 254, 55–58.
   PubMed Web of Science ®Google Scholar
• Beata Chertok, Allan E, David, Bradford A, Moffat, Victor C, Yang. (2009). Substantiating in vivo magnetic brain tumor targeting of cationic iron oxidenanocarriers via adsorptive surface masking. Biomaterials, 30, 1–8.
   Google Scholar
• Celeste Roney, Padmakar Kulkarni, Veera Arora, Peter Antich, Frederick Bonte, Aimei Wu, N.N., Mallikarjuana, Sanjeev Manohar, Hsiang-Fa Liang, Anandrao R., Kulkarni, Hsing-Wen Sung, Malladi Sairam, Tejraj M., Aminabhavi. (2005). Targeted nanoparticles for drug delivery through the blood–brain barrier for Alzheimer’s disease. Journal of Controlled Release, 108, 193–214.
   PubMed Web of Science ®Google Scholar
• Derossi D, Calvet S, Trembleau A, Brunissen A, Chassaing G, Prochiantz A. (1996). Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J Biol Chem, 271, 18188–18193.
   PubMed Web of Science ®Google Scholar
• Diky Mudhakir Hidetaka, Akita, Erdal Tan Hideyoshi, Harashima. (2008). A novel IRQ ligand-modified nano-carrier targeted to a unique pathway of caveolar endocytic pathway. Journal of Controlled Release, 22, 164–173.
   Google Scholar
• Loret EP, Vives E, Ho PS, Rochat H, Van Rietschoten J, Johnson WC Jr. (1991). Activating region of HIV-1 Tat protein: vacuum UV circular dichroism and energy minimization. Biochemistry, 30, 6013–6023.
   PubMed Web of Science ®Google Scholar
• Fawell S, Seery J, Daikh Y, Moore C, Chen LL, Pepinsky B, Barsoum J. (1994). Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci USA, 91, 664–668.
   PubMed Web of Science ®Google Scholar
• Belal F, Abdine H, Al-Majed A, Khalil NY. (2002). Spectrofluorimetric determination of vigabatrin and gabapentin in urine and dosage forms through derivatization with fluorescamine. J Pharm Biomed Anal, 27, 253–260.
   PubMed Web of Science ®Google Scholar
• Frangioni JV. (2003). In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol, 7, 626–634.
   PubMed Web of Science ®Google Scholar
• Futaki S, Suzuki T, Ohashi W, Yagami T, Tanaka S, Ueda K, Sugiura Y. (2001). Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem, 276, 5836–5840.
   PubMed Web of Science ®Google Scholar
• Gutierrez EG, Banks WA, Kastin AJ. (1993). Murine tumor necrosis factor α is transported from blood to brain in the mouse. J Neuroimmunol, 47, 169–176.
   PubMed Web of Science ®Google Scholar
• Hee Dong Han, Aeri Lee, Chung Kil Song, Taewon Hwang, Hasoo Seong, Chong Ock Lee, Byung Cheol Shin. (2006). In vivo distribution and antitumor activity of heparin-stabilized doxorubicin-loaded liposomes. International Journal of Pharmaceutics, 313, 181–188.
   PubMed Web of Science ®Google Scholar
• Huali Chen Lei Tang, Yao Qin Yujia Yin, Jie Tang Wenwei Tang, Xun Sun Zhirong Zhang, Ji Liu Qin He. (2010). Lactoferrin-modified procationic liposomes as a novel drug carrier for brain Delivery. European Journal of Pharmaceutical Sciences, 40, 94–102.
   PubMed Web of Science ®Google Scholar
• Ines Sauer, Ildiko R. Dunay, Karl Weisgraber, Michael Bienert, Margitta Dathe. (2005). An Apolipoprotein E-Derived Peptide Mediates Uptake of Sterically Stabilized Liposomes into Brain Capillary Endothelial Cells. Biochemistry, 44, 2021–2029.
   PubMed Web of Science ®Google Scholar
• Jolliet-Riant P, Tillement JP. (1999). Drug transfer across the blood-brain barrier and improvement of brain delivery. Fundam Clin Pharmacol, 13, 16–26.
   PubMed Web of Science ®Google Scholar
• Kim HR, Gil S, Andrieux K, Nicolas V, Appel M, Chacun H, Desmaële D, Taran F, Georgin D, Couvreur P. (2007). Low-density lipoprotein receptor-mediated endocytosis of PEGylated nanoparticles in rat brain endothelial cells. Cell Mol Life Sci, 64, 356–364.
   PubMed Web of Science ®Google Scholar
• Kitchens KM, Foraker AB, Kolhatkar RB, Swaan PW, Ghandehari H. (2007). Endocytosis and interaction of poly (amidoamine) dendrimers with Caco-2 cells. Pharm Res, 24, 2138–2145.
   PubMed Web of Science ®Google Scholar
• Lindgren M, Hällbrink M, Prochiantz A, Langel U. (2000). Cell-penetrating peptides. Trends Pharmacol Sci, 21, 99–103.
   PubMed Web of Science ®Google Scholar
• Lihong Liu Kun, Guo.; Jia Lu Subbu, S, Venkatraman Dan, Luo, Kian Chye Ng, Eng-Ang Ling, Shabbir Moochhala, Yi-Yan Yang. (2008). Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the bloodebrain barrier. Biomaterials, 29, 1509–1517.
   PubMed Web of Science ®Google Scholar
• May C., Miedel, Jeffrey D., Hulmes, Yu-Ching E., Pan, 1989. The use of fluorescamine as a detection reagent in protein microcharacterization. Journal of Biochemical and Biophysical Methods, 18, 37–52.
   PubMedGoogle Scholar
• Mrsny RJ, Volwerk JJ, Griffith OH. (1986). A simplified procedure for lipid phosphorus analysis shows that digestion rates vary with phospholipid structure. Chem Phys Lipids, 39, 185–191.
   PubMed Web of Science ®Google Scholar
• Ntziachristos V, Bremer C, Weissleder R. (2003). Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol, 13, 195–208.
   PubMed Web of Science ®Google Scholar
• Orlandi PA, Fishman PH. (1998). Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains. J Cell Biol, 141, 905–915.
   PubMed Web of Science ®Google Scholar
• Pardridge WM. (1994). New approaches to drug delivery through the blood-brain barrier. Trends Biotechnol, 12, 239–245.
   PubMed Web of Science ®Google Scholar
• Santra S, Yang H, Stanley JT, Holloway PH, Moudgil BM, Walter G, Mericle RA. (2005). Rapid and effective labeling of brain tissue using TAT-conjugated CdS:Mn/ZnS quantum dots. Chem Commun (Camb), 3144–3146.
   PubMed Web of Science ®Google Scholar
• Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF. (1999). In vivo protein transduction: delivery of a biologically active protein into the mouse. Science, 285, 1569–1572.
   PubMed Web of Science ®Google Scholar
• Schnitzer JE, Oh P, Pinney E, Allard J. (1994). Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J Cell Biol, 127, 1217–1232.
   PubMed Web of Science ®Google Scholar
• Futaki S, Ohashi W, Suzuki T, Niwa M, Tanaka S, Ueda K, Harashima H, Sugiura Y. (2001). Stearylated arginine-rich peptides: a new class of transfection systems. Bioconjug Chem, 12, 1005–1011.
   PubMed Web of Science ®Google Scholar
• Shiroh Futaki. (2002). Arginine-rich peptides: potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms. International Journal of Pharmaceutics, 245, 1–7.
   PubMed Web of Science ®Google Scholar
• Temsamani J, Scherrmann JM. (2003). Peptide vectors as drug carriers. Prog Drug Res, 61, 221–238.
   PubMedGoogle Scholar
• Temsamani J, Rousselle C, Rees AR, Scherrmann JM. (2001). Vector-mediated drug delivery to the brain. Expert Opin Biol Ther, 1, 773–782.
   PubMed Web of Science ®Google Scholar
• Triguero D, Buciak J, Pardridge WM. (1990). Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins. J Neurochem, 54, 1882–1888.
   PubMed Web of Science ®Google Scholar
• Vive`s, E, Brodin, P, Lebleu, B. (1997). A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem, 272, 16,010–16,017.
   Google Scholar
• Torchilin VP, Rammohan R, Weissig V, Levchenko TS. (2001). TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc Natl Acad Sci USA, 98, 8786–8791.
   PubMed Web of Science ®Google Scholar
• Wadia JS, Dowdy SF. (2002). Protein transduction technology. Curr Opin Biotechnol, 13, 52–56.
   PubMed Web of Science ®Google Scholar
• Wellington Pham, Bing-Qiao Zhao, Eng H., Lo Zdravka, Medarova, Bruce Rosen Anna, Moore. (2005). Crossing the blood–brain barrier: A potential application of myristoylated polyarginine for in vivo neuroimaging. NeuroImage, 28, 287–292.
   PubMed Web of Science ®Google Scholar
• Yao, Qin, Huali, Chen, Wenmin, Yuan, Rui, Kua, Qianyu, Zhang, Fulan, Xie, Li, Zhang, Zhirong, Zhang, Ji, Liu, Qin, He. (2011). Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery. Int J Pharm, 420, 304–312.
   PubMedGoogle Scholar
• Zhao M, Weissleder R. (2004). Intracellular cargo delivery using tat peptide and derivatives. Med Res Rev, 24, 1–12.
   PubMed Web of Science ®Google Scholar